Werbung ausblenden

News zu Aptorum

Aptorum Group Receives FDA Orphan Drug Designation for its SACT-1 Repurposed Drug For The Treatment of Neuroblastoma · Uhr · Business Wire
Aptorum Group Granted The First Patent for its SACT-1 Repurposed Drug For Treatment of Various Cancer Including but Not Limited to Neuroblastoma · Uhr · Business Wire
Aptorum Group Announces the Launch of its Oncology and Autoimmune Discovery and Development Platform Targeting Unmet Mutations and Novel Biomarkers · Uhr · Business Wire
Aptorum Group Announces Updates on the Clinical Validation of its RPIDD Infectious Disease Liquid Biopsy Technology · Uhr · Business Wire
Aptorum Group Limited Announces Results of 2021 Annual General Meeting of Shareholders · Uhr · Business Wire
Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 2, 2021 · Uhr · Business Wire